ANIMATION

Vasopressin V2-Receptor Blockage

Share this animation:

Hyponatremia is a condition characterized by low sodium concentration in blood serum. This may be caused by overactivity of anti-diuretic hormone, which results in increased reabsorption of water from the collecting duct. Tolvaptan is an FDA-approved antagonist of the vasopressin V2-receptor. Inhibition of this receptor prevents the expression of aquaporin channels along the collecting duct, promoting diuresis and correcting sodium levels in serum.

Share It:
Contact XVIVO

Client


Otsuka

I have had the pleasure of working closely with the XVIVO team for the past year and half as we prepared for launch. They have contributed to building a sound foundation for communicating our clinical messaging across multiple mediums and channels. XVIVO’s scientific rigor and technical expertise exceed any I have seen within the industry. The XVIVO team consists of highly professional engaging personnel that have mastered their respective areas of work. XVIVO are fun and engaging partners. The products that XVIVO consistently delivered elevated the power of our story.

Intuniv Marketing, Shire LLC.
Share this animation: